Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program | Journal for ImmunoTherapy of Cancer
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram
ASCO GU 2021: Best of Journals: Renal Cell Carcinoma – Medical Oncology
Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis
JCM | Free Full-Text | Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma | NEJM
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden | PLOS ONE
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text
Frontiers | Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
Duration of First-line Treatment with Molecular Targeted-Therapy Is a Prognostic Factor in Metastatic Renal Cell Carcinoma | Anticancer Research
The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database | Scientific Reports
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
